1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Fibromyalgia Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Cymbalta (Duloxetine) 1.2.3 Savella (Milnacipran) 1.2.4 Lyrica (Pregabalin) 1.2.5 Pancuronium 1.2.6 Others 1.3 Market by Application 1.3.1 Global Fibromyalgia Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Fibromyalgia Therapeutics Market Perspective (2017-2028) 2.2 Fibromyalgia Therapeutics Growth Trends by Region 2.2.1 Fibromyalgia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Fibromyalgia Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 Fibromyalgia Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 Fibromyalgia Therapeutics Market Dynamics 2.3.1 Fibromyalgia Therapeutics Industry Trends 2.3.2 Fibromyalgia Therapeutics Market Drivers 2.3.3 Fibromyalgia Therapeutics Market Challenges 2.3.4 Fibromyalgia Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Fibromyalgia Therapeutics Players by Revenue 3.1.1 Global Top Fibromyalgia Therapeutics Players by Revenue (2017-2022) 3.1.2 Global Fibromyalgia Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global Fibromyalgia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Fibromyalgia Therapeutics Revenue 3.4 Global Fibromyalgia Therapeutics Market Concentration Ratio 3.4.1 Global Fibromyalgia Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Therapeutics Revenue in 2021 3.5 Fibromyalgia Therapeutics Key Players Head office and Area Served 3.6 Key Players Fibromyalgia Therapeutics Product Solution and Service 3.7 Date of Enter into Fibromyalgia Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Fibromyalgia Therapeutics Breakdown Data by Type 4.1 Global Fibromyalgia Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Type (2023-2028) 5 Fibromyalgia Therapeutics Breakdown Data by Application 5.1 Global Fibromyalgia Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Fibromyalgia Therapeutics Market Size (2017-2028) 6.2 North America Fibromyalgia Therapeutics Market Size by Type 6.2.1 North America Fibromyalgia Therapeutics Market Size by Type (2017-2022) 6.2.2 North America Fibromyalgia Therapeutics Market Size by Type (2023-2028) 6.2.3 North America Fibromyalgia Therapeutics Market Share by Type (2017-2028) 6.3 North America Fibromyalgia Therapeutics Market Size by Application 6.3.1 North America Fibromyalgia Therapeutics Market Size by Application (2017-2022) 6.3.2 North America Fibromyalgia Therapeutics Market Size by Application (2023-2028) 6.3.3 North America Fibromyalgia Therapeutics Market Share by Application (2017-2028) 6.4 North America Fibromyalgia Therapeutics Market Size by Country 6.4.1 North America Fibromyalgia Therapeutics Market Size by Country (2017-2022) 6.4.2 North America Fibromyalgia Therapeutics Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Fibromyalgia Therapeutics Market Size (2017-2028) 7.2 Europe Fibromyalgia Therapeutics Market Size by Type 7.2.1 Europe Fibromyalgia Therapeutics Market Size by Type (2017-2022) 7.2.2 Europe Fibromyalgia Therapeutics Market Size by Type (2023-2028) 7.2.3 Europe Fibromyalgia Therapeutics Market Share by Type (2017-2028) 7.3 Europe Fibromyalgia Therapeutics Market Size by Application 7.3.1 Europe Fibromyalgia Therapeutics Market Size by Application (2017-2022) 7.3.2 Europe Fibromyalgia Therapeutics Market Size by Application (2023-2028) 7.3.3 Europe Fibromyalgia Therapeutics Market Share by Application (2017-2028) 7.4 Europe Fibromyalgia Therapeutics Market Size by Country 7.4.1 Europe Fibromyalgia Therapeutics Market Size by Country (2017-2022) 7.4.2 Europe Fibromyalgia Therapeutics Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Fibromyalgia Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type 8.2.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Fibromyalgia Therapeutics Market Share by Type (2017-2028) 8.3 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application 8.3.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Fibromyalgia Therapeutics Market Share by Application (2017-2028) 8.4 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region 8.4.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Fibromyalgia Therapeutics Market Size (2017-2028) 9.2 Latin America Fibromyalgia Therapeutics Market Size by Type 9.2.1 Latin America Fibromyalgia Therapeutics Market Size by Type (2017-2022) 9.2.2 Latin America Fibromyalgia Therapeutics Market Size by Type (2023-2028) 9.2.3 Latin America Fibromyalgia Therapeutics Market Share by Type (2017-2028) 9.3 Latin America Fibromyalgia Therapeutics Market Size by Application 9.3.1 Latin America Fibromyalgia Therapeutics Market Size by Application (2017-2022) 9.3.2 Latin America Fibromyalgia Therapeutics Market Size by Application (2023-2028) 9.3.3 Latin America Fibromyalgia Therapeutics Market Share by Application (2017-2028) 9.4 Latin America Fibromyalgia Therapeutics Market Size by Country 9.4.1 Latin America Fibromyalgia Therapeutics Market Size by Country (2017-2022) 9.4.2 Latin America Fibromyalgia Therapeutics Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Fibromyalgia Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type 10.2.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Fibromyalgia Therapeutics Market Share by Type (2017-2028) 10.3 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application 10.3.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Fibromyalgia Therapeutics Market Share by Application (2017-2028) 10.4 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country 10.4.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Fibromyalgia Therapeutics Introduction 11.1.4 Pfizer Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.1.5 Pfizer Recent Developments 11.2 Eli Lilly 11.2.1 Eli Lilly Company Details 11.2.2 Eli Lilly Business Overview 11.2.3 Eli Lilly Fibromyalgia Therapeutics Introduction 11.2.4 Eli Lilly Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.2.5 Eli Lilly Recent Developments 11.3 Actavis 11.3.1 Actavis Company Details 11.3.2 Actavis Business Overview 11.3.3 Actavis Fibromyalgia Therapeutics Introduction 11.3.4 Actavis Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.3.5 Actavis Recent Developments 11.4 Merck Sharp and Dohme 11.4.1 Merck Sharp and Dohme Company Details 11.4.2 Merck Sharp and Dohme Business Overview 11.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Introduction 11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.4.5 Merck Sharp and Dohme Recent Developments 11.5 Daiichi Sankyo 11.5.1 Daiichi Sankyo Company Details 11.5.2 Daiichi Sankyo Business Overview 11.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction 11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.5.5 Daiichi Sankyo Recent Developments 11.6 Innovative Med Concepts 11.6.1 Innovative Med Concepts Company Details 11.6.2 Innovative Med Concepts Business Overview 11.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Introduction 11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.6.5 Innovative Med Concepts Recent Developments 11.7 Meda 11.7.1 Meda Company Details 11.7.2 Meda Business Overview 11.7.3 Meda Fibromyalgia Therapeutics Introduction 11.7.4 Meda Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.7.5 Meda Recent Developments 11.8 Meiji Seika 11.8.1 Meiji Seika Company Details 11.8.2 Meiji Seika Business Overview 11.8.3 Meiji Seika Fibromyalgia Therapeutics Introduction 11.8.4 Meiji Seika Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.8.5 Meiji Seika Recent Developments 11.9 Switch Biotech 11.9.1 Switch Biotech Company Details 11.9.2 Switch Biotech Business Overview 11.9.3 Switch Biotech Fibromyalgia Therapeutics Introduction 11.9.4 Switch Biotech Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.9.5 Switch Biotech Recent Developments 11.10 Theravance 11.10.1 Theravance Company Details 11.10.2 Theravance Business Overview 11.10.3 Theravance Fibromyalgia Therapeutics Introduction 11.10.4 Theravance Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.10.5 Theravance Recent Developments 11.11 Zynerba Pharmaceuticals 11.11.1 Zynerba Pharmaceuticals Company Details 11.11.2 Zynerba Pharmaceuticals Business Overview 11.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Introduction 11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.11.5 Zynerba Pharmaceuticals Recent Developments 11.12 Tonix Pharmaceuticals Holding Corp. (TNXP) 11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details 11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview 11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Introduction 11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments 11.13 Daiichi Sankyo 11.13.1 Daiichi Sankyo Company Details 11.13.2 Daiichi Sankyo Business Overview 11.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction 11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.13.5 Daiichi Sankyo Recent Developments 11.14 Forest Pharmaceuticals, Inc. 11.14.1 Forest Pharmaceuticals, Inc. Company Details 11.14.2 Forest Pharmaceuticals, Inc. Business Overview 11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Introduction 11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.14.5 Forest Pharmaceuticals, Inc. Recent Developments 11.15 Boehringer Ingelheim GmbH 11.15.1 Boehringer Ingelheim GmbH Company Details 11.15.2 Boehringer Ingelheim GmbH Business Overview 11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Introduction 11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.15.5 Boehringer Ingelheim GmbH Recent Developments 11.16 Pierre Fabre Mdicament 11.16.1 Pierre Fabre Mdicament Company Details 11.16.2 Pierre Fabre Mdicament Business Overview 11.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Introduction 11.16.4 Pierre Fabre Mdicament Revenue in Fibromyalgia Therapeutics Business (2017-2022) 11.16.5 Pierre Fabre Mdicament Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Fibromyalgia Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Cymbalta (Duloxetine) Table 3. Key Players of Savella (Milnacipran) Table 4. Key Players of Lyrica (Pregabalin) Table 5. Key Players of Pancuronium Table 6. Key Players of Others Table 7. Global Fibromyalgia Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 8. Global Fibromyalgia Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Fibromyalgia Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Fibromyalgia Therapeutics Market Share by Region (2017-2022) Table 11. Global Fibromyalgia Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Fibromyalgia Therapeutics Market Share by Region (2023-2028) Table 13. Fibromyalgia Therapeutics Market Trends Table 14. Fibromyalgia Therapeutics Market Drivers Table 15. Fibromyalgia Therapeutics Market Challenges Table 16. Fibromyalgia Therapeutics Market Restraints Table 17. Global Fibromyalgia Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Fibromyalgia Therapeutics Revenue Share by Players (2017-2022) Table 19. Global Top Fibromyalgia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Therapeutics as of 2021) Table 20. Ranking of Global Top Fibromyalgia Therapeutics Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Fibromyalgia Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Fibromyalgia Therapeutics Product Solution and Service Table 24. Date of Enter into Fibromyalgia Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Fibromyalgia Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2017-2022) Table 28. Global Fibromyalgia Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2023-2028) Table 30. Global Fibromyalgia Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Fibromyalgia Therapeutics Revenue Share by Application (2017-2022) Table 32. Global Fibromyalgia Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Fibromyalgia Therapeutics Revenue Share by Application (2023-2028) Table 34. North America Fibromyalgia Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 35. North America Fibromyalgia Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 36. North America Fibromyalgia Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 37. North America Fibromyalgia Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 38. North America Fibromyalgia Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 39. North America Fibromyalgia Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 40. Europe Fibromyalgia Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 41. Europe Fibromyalgia Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 42. Europe Fibromyalgia Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 43. Europe Fibromyalgia Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 44. Europe Fibromyalgia Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 45. Europe Fibromyalgia Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 46. Asia Pacific Fibromyalgia Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 47. Asia Pacific Fibromyalgia Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 48. Asia Pacific Fibromyalgia Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 49. Asia Pacific Fibromyalgia Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 50. Asia Pacific Fibromyalgia Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 51. Asia Pacific Fibromyalgia Therapeutics Market Size by Region (2023-2028) & (US$ Million) Table 52. Latin America Fibromyalgia Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 53. Latin America Fibromyalgia Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 54. Latin America Fibromyalgia Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 55. Latin America Fibromyalgia Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 56. Latin America Fibromyalgia Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 57. Latin America Fibromyalgia Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 58. Middle East and Africa Fibromyalgia Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 59. Middle East and Africa Fibromyalgia Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 60. Middle East and Africa Fibromyalgia Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 61. Middle East and Africa Fibromyalgia Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 62. Middle East and Africa Fibromyalgia Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 63. Middle East and Africa Fibromyalgia Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 64. Pfizer Company Details Table 65. Pfizer Business Overview Table 66. Pfizer Fibromyalgia Therapeutics Product Table 67. Pfizer Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 68. Pfizer Recent Developments Table 69. Eli Lilly Company Details Table 70. Eli Lilly Business Overview Table 71. Eli Lilly Fibromyalgia Therapeutics Product Table 72. Eli Lilly Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 73. Eli Lilly Recent Developments Table 74. Actavis Company Details Table 75. Actavis Business Overview Table 76. Actavis Fibromyalgia Therapeutics Product Table 77. Actavis Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 78. Actavis Recent Developments Table 79. Merck Sharp and Dohme Company Details Table 80. Merck Sharp and Dohme Business Overview Table 81. Merck Sharp and Dohme Fibromyalgia Therapeutics Product Table 82. Merck Sharp and Dohme Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 83. Merck Sharp and Dohme Recent Developments Table 84. Daiichi Sankyo Company Details Table 85. Daiichi Sankyo Business Overview Table 86. Daiichi Sankyo Fibromyalgia Therapeutics Product Table 87. Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 88. Daiichi Sankyo Recent Developments Table 89. Innovative Med Concepts Company Details Table 90. Innovative Med Concepts Business Overview Table 91. Innovative Med Concepts Fibromyalgia Therapeutics Product Table 92. Innovative Med Concepts Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 93. Innovative Med Concepts Recent Developments Table 94. Meda Company Details Table 95. Meda Business Overview Table 96. Meda Fibromyalgia Therapeutics Product Table 97. Meda Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 98. Meda Recent Developments Table 99. Meiji Seika Company Details Table 100. Meiji Seika Business Overview Table 101. Meiji Seika Fibromyalgia Therapeutics Product Table 102. Meiji Seika Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 103. Meiji Seika Recent Developments Table 104. Switch Biotech Company Details Table 105. Switch Biotech Business Overview Table 106. Switch Biotech Fibromyalgia Therapeutics Product Table 107. Switch Biotech Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 108. Switch Biotech Recent Developments Table 109. Theravance Company Details Table 110. Theravance Business Overview Table 111. Theravance Fibromyalgia Therapeutics Product Table 112. Theravance Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 113. Theravance Recent Developments Table 114. Zynerba Pharmaceuticals Company Details Table 115. Zynerba Pharmaceuticals Business Overview Table 116. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Product Table 117. Zynerba Pharmaceuticals Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 118. Zynerba Pharmaceuticals Recent Developments Table 119. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details Table 120. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview Table 121. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Product Table 122. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 123. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments Table 124. Daiichi Sankyo Company Details Table 125. Daiichi Sankyo Business Overview Table 126. Daiichi Sankyo Fibromyalgia Therapeutics Product Table 127. Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 128. Daiichi Sankyo Recent Developments Table 129. Forest Pharmaceuticals, Inc. Company Details Table 130. Forest Pharmaceuticals, Inc. Business Overview Table 131. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Product Table 132. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 133. Forest Pharmaceuticals, Inc. Recent Developments Table 134. Boehringer Ingelheim GmbH Company Details Table 135. Boehringer Ingelheim GmbH Business Overview Table 136. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Product Table 137. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 138. Boehringer Ingelheim GmbH Recent Developments Table 139. Pierre Fabre Mdicament Company Details Table 140. Pierre Fabre Mdicament Business Overview Table 141. Pierre Fabre Mdicament Fibromyalgia Therapeutics Product Table 142. Pierre Fabre Mdicament Revenue in Fibromyalgia Therapeutics Business (2017-2022) & (US$ Million) Table 143. Pierre Fabre Mdicament Recent Developments Table 144. Research Programs/Design for This Report Table 145. Key Data Information from Secondary Sources Table 146. Key Data Information from Primary Sources List of Figures Figure 1. Global Fibromyalgia Therapeutics Market Share by Type: 2021 VS 2028 Figure 2. Cymbalta (Duloxetine) Features Figure 3. Savella (Milnacipran) Features Figure 4. Lyrica (Pregabalin) Features Figure 5. Pancuronium Features Figure 6. Others Features Figure 7. Global Fibromyalgia Therapeutics Market Share by Application: 2021 VS 2028 Figure 8. Hospital Case Studies Figure 9. Clinic Case Studies Figure 10. Others Case Studies Figure 11. Fibromyalgia Therapeutics Report Years Considered Figure 12. Global Fibromyalgia Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Fibromyalgia Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Fibromyalgia Therapeutics Market Share by Region: 2021 VS 2028 Figure 15. Global Fibromyalgia Therapeutics Market Share by Players in 2021 Figure 16. Global Top Fibromyalgia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Therapeutics as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Fibromyalgia Therapeutics Revenue in 2021 Figure 18. North America Fibromyalgia Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 19. North America Fibromyalgia Therapeutics Market Size Market Share by Type (2017-2028) Figure 20. North America Fibromyalgia Therapeutics Market Size Market Share by Application (2017-2028) Figure 21. North America Fibromyalgia Therapeutics Market Size Share by Country (2017-2028) Figure 22. United States Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Fibromyalgia Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 25. Europe Fibromyalgia Therapeutics Market Size Market Share by Type (2017-2028) Figure 26. Europe Fibromyalgia Therapeutics Market Size Market Share by Application (2017-2028) Figure 27. Europe Fibromyalgia Therapeutics Market Size Share by Country (2017-2028) Figure 28. Germany Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. France Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. U.K. Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Italy Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Russia Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Nordic Countries Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Fibromyalgia Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 35. Asia Pacific Fibromyalgia Therapeutics Market Size Market Share by Type (2017-2028) Figure 36. Asia Pacific Fibromyalgia Therapeutics Market Size Market Share by Application (2017-2028) Figure 37. Asia Pacific Fibromyalgia Therapeutics Market Size Share by Region (2017-2028) Figure 38. China Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Japan Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. South Korea Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Southeast Asia Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. India Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Australia Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 44. Latin America Fibromyalgia Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 45. Latin America Fibromyalgia Therapeutics Market Size Market Share by Type (2017-2028) Figure 46. Latin America Fibromyalgia Therapeutics Market Size Market Share by Application (2017-2028) Figure 47. Latin America Fibromyalgia Therapeutics Market Size Share by Country (2017-2028) Figure 48. Mexico Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Brazil Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Fibromyalgia Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 51. Middle East and Africa Fibromyalgia Therapeutics Market Size Market Share by Type (2017-2028) Figure 52. Middle East and Africa Fibromyalgia Therapeutics Market Size Market Share by Application (2017-2028) Figure 53. Middle East and Africa Fibromyalgia Therapeutics Market Size Share by Country (2017-2028) Figure 54. Turkey Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Saudi Arabia Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. UAE Fibromyalgia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Pfizer Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 58. Eli Lilly Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 59. Actavis Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 60. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 61. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 62. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 63. Meda Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 64. Meiji Seika Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 65. Switch Biotech Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 66. Theravance Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 67. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 68. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 69. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 70. Forest Pharmaceuticals, Inc. Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 71. Boehringer Ingelheim GmbH Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 72. Pierre Fabre Mdicament Revenue Growth Rate in Fibromyalgia Therapeutics Business (2017-2022) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Pfizer Eli Lilly Actavis Merck Sharp and Dohme Daiichi Sankyo Innovative Med Concepts Meda Meiji Seika Switch Biotech Theravance Zynerba Pharmaceuticals Tonix Pharmaceuticals Holding Corp. (TNXP) Daiichi Sankyo Forest Pharmaceuticals, Inc. Boehringer Ingelheim GmbH Pierre Fabre Mdicament